Page 77 - 2019_10 resto del Mondo_web

Molecular diagnosis and clinical features of 117 Japanese FA patients
et al. Analysis of component findings in 79 patients diagnosed with VACTERL associa- tion. Am J Med Genet A. 2010;152A(9): 2236-2244.
28. Alter BP, Rosenberg PS. VACTERL-H Association and Fanconi Anemia. Mol Syndromol. 2013;4(1-2):87–93.
29. van Twest S, Murphy VJ, Hodson C, et al. Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway. Mol Cell. 2017;65(2):247-259.
30. McCauley J, Masand N, McGowan R, et al. X-linked VACTERL with hydrocephalus syndrome: further delineation of the pheno- type caused by FANCB mutations. Am J Med Genet A. 2011;155A(10):2370-2380.
31. Krawczak M, Thomas NST, Hundrieser B, et al. Single base-pair substitutions in exon- intron junctions of human genes: nature, dis- tribution, and consequences for mRNA splicing. Hum Mutat. 2007;28(2):150-158.
32. Ikeda H, Matsushita M, Waisfisz Q, et al. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2. Cancer Res. 2003;63(10):2688-2694.
33. Bakker JL, Thirthagiri E, van Mil SE, et al. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnos- tics. Hum Mutat. 2014;35(4):442-446.
34. Alter BP, Rosenberg PS, Brody LC. Clinical and molecular features associated with bial- lelic mutations in FANCD1/BRCA2. J Med Genet. 2007;44(1):1-9.
35. Xia B, Sheng Q, Nakanishi K, et al. Control of BRCA2 cellular and clinical functions by a
nuclear partner, PALB2. Mol Cell. 2006;
22(6):719-729.
36. Luijsterburg MS, Typas D, Caron M-C, et al.
A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation. Elife. 2017;6.
37. Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39(2): 162-164.
38. Wagner JE, Tolar J, Levran O, et al. Germline mutations in BRCA2: shared genetic suscep- tibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood. 2004;103(8):3226-3229.
39. Prakash R, Zhang Y, Feng W, Jasin M. Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins. Cold Spring Harb Perspect Biol. 2015;7(4):a016600.
40. Katsuki Y, Takata M. Defects in homologous recombination repair behind the human dis- eases: FA and HBOC. Endocr Relat Cancer. 2016;23(10):T19-37.
41. Paulo P, Maia S, Pinto C, et al. Targeted next generation sequencing identifies functional- ly deleterious germline mutations in novel genes in early-onset/familial prostate cancer. PLoS Genet. 2018;14(4):e1007355.
42. Hirotsu Y, Nakagomi H, Sakamoto I, Amemiya K, Mochizuki H, Omata M. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing. Mol Genet Genomic Med. 2015;3(2):121-129.
43. Borg A, Haile RW, Malone KE, et al. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat. 2010;31(3):E1200-1240.
44. Nakagomi H, Hirotsu Y, Okimoto K, et al. PALB2 mutation in a woman with bilateral breast cancer: A case report. Mol Clin Oncol. 2017;6(4):556-560.
45. Gross ER, Zambelli VO, Small BA, Ferreira JCB, Chen C-H, Mochly-Rosen D. A person- alized medicine approach for Asian Americans with the aldehyde dehydroge- nase 2*2 variant. Annu Rev Pharmacol Toxicol. 2015;55:107-127.
46. Rosenberg PS, Huang Y, Alter BP. Individualized risks of first adverse events in patients with Fanconi anemia. Blood. 2004;104(2):350-355.
47. Holden ST, Cox JJ, Kesterton I, Thomas NS, Carr C, Woods CG. Fanconi anaemia com- plementation group B presenting as X linked VACTERL with hydrocephalus syndrome. J Med Genet. 2006;43(9):750-754.
48. Savage SA, Ballew BJ, Giri N, et al. Novel FANCI mutations in Fanconi anemia with VACTERL association. Am J Med Genet A. 2016;170A(2):386-391.
49. Yabe M, Yabe H. [Diagnosis and manage- ment of inherited bone marrow failure syn- drome]. Rinsho Ketsueki. 2015;56(10):1914- 1921.
50. Rogers KJ, Fu W, Akey JM, Monnat RJ. Global and disease-associated genetic variation in the human Fanconi anemia gene family. Hum Mol Genet. 2014;23(25):6815-6825.
haematologica | 2019; 104(10)
1973